Hicham Skali

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. doi request reprint Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm
    Hicham Skali
    Department of Medicine, Harvard Medical School, Brigham and Women s Hospital, Boston, MA 02115, USA
    Am J Kidney Dis 61:238-46. 2013
  2. doi request reprint Prognostic assessment of estimated glomerular filtration rate by the new Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease Study equation
    Hicham Skali
    Cardiovascular Division, Brigham and Women s Hospital, Boston, MA 02115, USA
    Am Heart J 162:548-54. 2011
  3. doi request reprint Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study
    Anil Verma
    Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    JACC Cardiovasc Imaging 1:582-91. 2008
  4. doi request reprint High-risk myocardial infarction in the young: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial
    Rachel E Anderson
    Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02445, USA
    Am Heart J 155:706-11. 2008
  5. ncbi request reprint Comparison of regional versus global assessment of left ventricular function in patients with left ventricular dysfunction, heart failure, or both after myocardial infarction: the valsartan in acute myocardial infarction echocardiographic study
    Jens Jakob Thune
    Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    J Am Soc Echocardiogr 19:1462-5. 2006
  6. ncbi request reprint Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients
    Scott D Solomon
    Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Boston, MA 02445, USA
    Circulation 112:3738-44. 2005
  7. ncbi request reprint Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: the VALIANT experience
    Kent Stephenson
    Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Heart Rhythm 4:308-13. 2007
  8. ncbi request reprint Risk assessment in patients with depressed left ventricular function after myocardial infarction using the myocardial performance index--Survival and Ventricular Enlargement (SAVE) experience
    Nagesh S Anavekar
    Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    J Am Soc Echocardiogr 19:28-33. 2006
  9. ncbi request reprint Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure
    Scott D Solomon
    Cardiovascular Division, Brigham and Women s Hospital, 75 Francis St, Boston, MA 02115, USA
    Circulation 116:1482-7. 2007
  10. doi request reprint Left ventricular systolic and diastolic function, remodelling, and clinical outcomes among patients with diabetes following myocardial infarction and the influence of direct renin inhibition with aliskiren
    Amil M Shah
    Division of Cardiovascular Medicine, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02445, USA
    Eur J Heart Fail 14:185-92. 2012

Detail Information

Publications47

  1. doi request reprint Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm
    Hicham Skali
    Department of Medicine, Harvard Medical School, Brigham and Women s Hospital, Boston, MA 02115, USA
    Am J Kidney Dis 61:238-46. 2013
    ..We intended to describe Hb level trends over time with no or minimal administration of erythropoiesis-stimulating agents...
  2. doi request reprint Prognostic assessment of estimated glomerular filtration rate by the new Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease Study equation
    Hicham Skali
    Cardiovascular Division, Brigham and Women s Hospital, Boston, MA 02115, USA
    Am Heart J 162:548-54. 2011
    ..We aimed to assess the incremental prognostic accuracy of eGFR(CKD-EPI) versus eGFR(MDRD) in subjects at increased risk for CV disease...
  3. doi request reprint Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study
    Anil Verma
    Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    JACC Cardiovasc Imaging 1:582-91. 2008
    ..This study sought to understand prognostic implications of increased baseline left ventricular (LV) mass and geometric patterns in a high risk acute myocardial infarction...
  4. doi request reprint High-risk myocardial infarction in the young: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial
    Rachel E Anderson
    Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02445, USA
    Am Heart J 155:706-11. 2008
    ..We examined characteristics, cardiovascular outcomes, and the influence of risk factors on outcomes in young survivors of AMI...
  5. ncbi request reprint Comparison of regional versus global assessment of left ventricular function in patients with left ventricular dysfunction, heart failure, or both after myocardial infarction: the valsartan in acute myocardial infarction echocardiographic study
    Jens Jakob Thune
    Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    J Am Soc Echocardiogr 19:1462-5. 2006
    ..Left ventricular (LV) ejection fraction (EF) and wall-motion index (WMI) have both been shown to be independent predictors of outcome after myocardial infarction (MI)...
  6. ncbi request reprint Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients
    Scott D Solomon
    Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Boston, MA 02445, USA
    Circulation 112:3738-44. 2005
    ..The growing number of patients with preserved systolic function heart failure underscores the importance of understanding the relationship between ejection fraction and risk...
  7. ncbi request reprint Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: the VALIANT experience
    Kent Stephenson
    Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Heart Rhythm 4:308-13. 2007
    ....
  8. ncbi request reprint Risk assessment in patients with depressed left ventricular function after myocardial infarction using the myocardial performance index--Survival and Ventricular Enlargement (SAVE) experience
    Nagesh S Anavekar
    Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    J Am Soc Echocardiogr 19:28-33. 2006
    ..The prognostic significance of MPI is less clear for cardiovascular (CV) events after myocardial infarction (MI) among individuals at high risk with depressed left ventricular (LV) systolic function...
  9. ncbi request reprint Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure
    Scott D Solomon
    Cardiovascular Division, Brigham and Women s Hospital, 75 Francis St, Boston, MA 02115, USA
    Circulation 116:1482-7. 2007
    ....
  10. doi request reprint Left ventricular systolic and diastolic function, remodelling, and clinical outcomes among patients with diabetes following myocardial infarction and the influence of direct renin inhibition with aliskiren
    Amil M Shah
    Division of Cardiovascular Medicine, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02445, USA
    Eur J Heart Fail 14:185-92. 2012
    ..We assessed the relationship between diabetes and cardiac structure and function following myocardial infarction (MI) and whether diabetes influences the effect of direct renin inhibition on change in left ventricular (LV) size...
  11. ncbi request reprint Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program
    Satish Kenchaiah
    Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass 02115, USA
    Circulation 116:627-36. 2007
    ..However, in patients with certain specific chronic diseases, including heart failure, low BMI has been associated with increased mortality...
  12. ncbi request reprint Association of QRS duration and outcomes after myocardial infarction: the VALIANT trial
    Lakshminarayan Yerra
    Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
    Heart Rhythm 3:313-6. 2006
    ..The association of QRS duration with clinical outcomes in the post-myocardial infarction (MI) setting is less well defined...
  13. doi request reprint Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure: results from the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) program
    Davide Castagno
    Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    J Am Coll Cardiol 59:1785-95. 2012
    ..The aim of this study was to explore the relationship between baseline resting heart rate and outcomes in patients with chronic heart failure (HF) according to baseline left ventricular ejection fraction (LVEF) and cardiac rhythm...
  14. ncbi request reprint Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic study
    Scott D Solomon
    Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02445, USA
    Am Heart J 150:257-62. 2005
    ..Angiotensin-converting enzyme (ACE) inhibition attenuates ventricular remodeling and improves ventricular function in heart failure patients. Vasopeptidase inhibition has shown similar effects in experimental models...
  15. pmc Yield of downstream tests after exercise treadmill testing: a prospective cohort study
    Mitalee P Christman
    Harvard Medical School, Boston, Massachusetts
    J Am Coll Cardiol 63:1264-74. 2014
    ..The purpose of this study was to estimate the frequency and results of downstream testing after exercise treadmill tests (ETTs)...
  16. ncbi request reprint Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial
    David Aguilar
    Cardiovascular Division, University of Texas Health Science Center, 6431 Fannin, MSB 1 246, Houston, TX 77030, USA
    Circulation 110:1572-8. 2004
    ..A prior diagnosis of diabetes mellitus is associated with adverse outcomes after acute myocardial infarction (MI), but the risk associated with a new diagnosis of diabetes in this setting has not been well defined...
  17. ncbi request reprint Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function
    Maria Amigoni
    Brigham and Women s Hospital, Boston, Massachusetts, USA
    Eur Heart J 28:326-33. 2007
    ....
  18. pmc Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis
    Ron Blankstein
    Noninvasive Cardiovascular Imaging Program, Department of Medicine Cardiovascular Division and Department of Radiology, Brigham and Women s Hospital, Boston, Massachusetts Cardiovascular Division, Brigham and Women s Hospital, Boston, Massachusetts Electronic address
    J Am Coll Cardiol 63:329-36. 2014
    ..This study sought to relate imaging findings on positron emission tomography (PET) to adverse cardiac events in patients referred for evaluation of known or suspected cardiac sarcoidosis...
  19. doi request reprint Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience
    Hicham Skali
    Brigham and Women s Hospital, Cardiovascular Division, 75 Francis St, Boston, MA 02115, USA
    Circulation 124:2903-8. 2011
    ..We sought to identify baseline characteristics and postrandomization factors that might explain this association...
  20. doi request reprint Cardiac structure and function, remodeling, and clinical outcomes among patients with diabetes after myocardial infarction complicated by left ventricular systolic dysfunction, heart failure, or both
    Amil M Shah
    Division of Cardiovascular Medicine, Brigham and Women s Hospital, Boston, MA 02445, USA
    Am Heart J 162:685-91. 2011
    ..We hypothesized that after high-risk MI, patients with diabetes would demonstrate patterns of remodeling that are suggestive of reduced ventricular compliance and that are associated with an increased risk of death or HF...
  21. ncbi request reprint Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction
    Powell Jose
    Cardiovascular Division, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
    J Am Soc Nephrol 17:2886-91. 2006
    ..Monitoring serum creatinine in patients during the first few weeks after MI may help to identify those who are at highest risk and guide effective long-term therapeutic choices...
  22. doi request reprint Incremental value of echocardiographic assessment beyond clinical evaluation for prediction of death and development of heart failure after high-risk myocardial infarction
    Anil Verma
    Cardiovascular Division, Ochsner Medical Center, New Orleans, LA, USA
    Am Heart J 161:1156-62. 2011
    ..However, the extent to which measures of LV structure and function provide incremental prognostic value over clinical variables in survivors of high-risk myocardial infarction has not been well defined...
  23. ncbi request reprint Rationale and design of a multicenter echocardiographic study to assess the relationship between cardiac structure and function and heart failure risk in a biracial cohort of community-dwelling elderly persons: the Atherosclerosis Risk in Communities stud
    Amil M Shah
    Cardiovascular Division, Brigham and Women s Hospital, Boston, MA
    Circ Cardiovasc Imaging 7:173-81. 2014
    ..Limited normative and prognostic data exist on measures of cardiac structure, diastolic function, and novel measures of systolic deformation in older adults living in the community...
  24. ncbi request reprint Prognostic use of echocardiography 1 year after a myocardial infarction
    Hicham Skali
    Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Am Heart J 150:743-9. 2005
    ..However, the prognostic use of a late evaluation of cardiac function after an MI remains unclear...
  25. ncbi request reprint Ventricular remodeling does not accompany the development of heart failure in diabetic patients after myocardial infarction
    Scott D Solomon
    Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Boston, Mass 02115, USA
    Circulation 106:1251-5. 2002
    ..We used data from the Survival and Ventricular Enlargement (SAVE) echocardiographic substudy to test the hypothesis that diabetes was associated with increased LV enlargement after MI...
  26. ncbi request reprint Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction
    Scott D Solomon
    Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass 02115, USA
    Circulation 111:3411-9. 2005
    ....
  27. ncbi request reprint Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program
    Scott D Solomon
    Cardiovascular Division, Brigham and Women s Hospital, 75 Francis St, Boston, Mass 02445, USA
    Circulation 110:2180-3. 2004
    ..We assessed the effect of candesartan on cause-specific mortality in patients enrolled in the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program...
  28. ncbi request reprint Comparison of the use of downstream tests after exercise treadmill testing by cardiologists versus noncardiologists
    Marcio S Bittencourt
    Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts Department of Radiology, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts
    Am J Cardiol 114:305-11. 2014
    ..The lower rate of tests is driven by a lower rate of tests after positive or inconclusive ETT. ..
  29. pmc Differential influence of distinct components of increased blood pressure on cardiovascular outcomes: from the atherosclerosis risk in communities study
    Susan Cheng
    Brigham and Women s Hospital, Cardiovascular Division, 75 Francis St, Boston, MA 02115, USA
    Hypertension 62:492-8. 2013
    ..74). With few exceptions, results were similar in analyses stratified by age, sex, and race. Our data indicate that distinct BP components contribute variably to risk for different cardiovascular outcomes...
  30. doi request reprint Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunction
    Scott D Solomon
    Cardiovascular Division, Brigham and Women s Hospital, Boston, MA, USA
    Eur Heart J 32:1227-34. 2011
    ....
  31. ncbi request reprint Alcohol consumption and prognosis in patients with left ventricular systolic dysfunction after a myocardial infarction
    David Aguilar
    Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    J Am Coll Cardiol 43:2015-21. 2004
    ..We assessed the influence of alcohol intake on the development of symptomatic heart failure (HF) in patients with left ventricular (LV) dysfunction after a myocardial infarction (MI)...
  32. doi request reprint Detection of obstructive coronary artery disease using regadenoson stress and 82Rb PET/CT myocardial perfusion imaging
    Edward Hsiao
    Noninvasive Cardiovascular Imaging Program, Departments of Medicine Cardiology and Radiology, Brigham and Women s Hospital, Boston, Massachusetts and
    J Nucl Med 54:1748-54. 2013
    ..Our objective was to study the diagnostic performance of regadenoson (82)Rb myocardial perfusion PET imaging to detect obstructive coronary artery disease (CAD)...
  33. pmc 18F-FDG PET/CT for the assessment of myocardial sarcoidosis
    Hicham Skali
    Department of Medicine, Cardiovascular Division, Boston, MA 02115, USA
    Curr Cardiol Rep 15:352. 2013
    ..Accumulating data support the growing role of 18F-fluorodeoxyglucose (18F-FDG)PET in the diagnosis and risk stratification of patients with cardiac sarcoidosis...
  34. doi request reprint Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both
    Anne Catherine Pouleur
    Cardiovascular Division, Brigham and Women s Hospital, Boston, MA 02115, USA
    Circulation 122:597-602. 2010
    ....
  35. ncbi request reprint Variable impact of combining fatal and nonfatal end points in heart failure trials
    Hicham Skali
    Brigham and Women s Hospital, 75 Francis St, Boston, MA 02115, USA
    Circulation 114:2298-303. 2006
    ..Longer-duration trials have a more predictable increase in events than short RCTs. Trial duration must be considered when composite end points are used during the design and interpretation of HF RCTs...
  36. ncbi request reprint Prognostic significance of troponin elevation and right ventricular enlargement in acute pulmonary embolism
    Tudor Scridon
    Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Am J Cardiol 96:303-5. 2005
    ..Patients with elevated troponin and right ventricular enlargement are at significantly greater risk for death after PE than patients with only 1 or with neither adverse prognostic marker...
  37. pmc Mortality rates in trials of subjects with type 2 diabetes
    Ebrahim Barkoudah
    Cardiovascular Division, Dana Farber Cancer Institute, Boston, MA E B, H S, S D S, M A P General Medicine Division, Brigham and Women s Hospital, Dana Farber Cancer Institute, Boston, MA E B
    J Am Heart Assoc 1:8-15. 2012
    ..In randomized controlled trials (RCTs) of subjects with type 2 diabetes mellitus, mortality rates vary substantially. We sought to examine the inclusion and exclusion criteria of these RCTs to explore relationships with mortality...
  38. doi request reprint Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study)
    Nagesh S Anavekar
    Department of Cardiology, Austin Health, University of Melbourne, Melbourne, Australia
    Am J Cardiol 101:607-12. 2008
    ..53 (95% CI 1.24 to 1.88) increased risk of fatal and nonfatal CV outcomes. In conclusion, decreased right ventricular systolic function is a major risk factor for death, sudden death, HF, and stroke after MI...
  39. ncbi request reprint Two-dimensional assessment of right ventricular function: an echocardiographic-MRI correlative study
    Nagesh S Anavekar
    Cardiovascular Clinical Trials Unit, Austin Health, University of Melbourne, Melbourne, Australia
    Echocardiography 24:452-6. 2007
    ..Hence, quantitative estimation of RV function has proven difficult in clinical practice...
  40. doi request reprint Reduction in ¹⁸F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis
    Michael T Osborne
    Department of Medicine, Brigham and Women s Hospital, Boston, MA, USA
    J Nucl Cardiol 21:166-74. 2014
    ..It is not known whether a reduction in myocardial inflammation, as measured by FDG uptake, is associated with improvement in LV ejection fraction (EF)...
  41. pmc Assessment of myocardial viability and left ventricular function in patients supported by a left ventricular assist device
    Deepak K Gupta
    Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts
    J Heart Lung Transplant 33:372-81. 2014
    ..We aimed to develop a non-invasive imaging protocol to serially quantify native cardiac structure, function, and myocardial viability while at reduced LVAD support...
  42. doi request reprint (18)F-FDG PET/CT for the Assessment of Myocardial Sarcoidosis
    Hicham Skali
    Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, 70 Francis Street, Shapiro 5th Floor, Room 128, Boston, MA, 02115, USA
    Curr Cardiol Rep 15:370. 2013
    ..Accumulating data support the growing role of (18)F-fluorodeoxyglucose ((18)F-FDG) PET in the diagnosis and risk stratification of patients with cardiac sarcoidosis...
  43. pmc Safety and feasibility of regadenoson use for suboptimal heart rate response during symptom-limited standard Bruce exercise stress test
    Sara L Partington
    Noninvasive Cardiovascular Imaging Program, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    J Nucl Cardiol 19:970-8. 2012
    ..Our aim was to study the feasibility and safety of regadenoson injection at peak ETT for submaximal heart rate (HR) response...
  44. pmc Cardiovascular manifestations of Fabry disease: relationships between left ventricular hypertrophy, disease severity, and alpha-galactosidase A activity
    Justina C Wu
    Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
    Eur Heart J 31:1088-97. 2010
    ..This study analysed the cardiovascular manifestations of a cohort of Fabry patients, and sought to define relationships between disease severity, alphagal activity, and cardiac abnormalities...
  45. ncbi request reprint Prognosis and response to therapy of first inpatient and outpatient heart failure event in a heart failure clinical trial: MADIT-CRT
    Hicham Skali
    Harvard Medical School, Brigham and Women s Hospital, Cardiovascular Division, Boston, MA, USA
    Eur J Heart Fail 16:560-5. 2014
    ..Whether outpatient management of HF exacerbation carries similar prognostic and therapeutic information is less well known, but could be important for the design of trials that use HF hospitalization as an endpoint...
  46. ncbi request reprint Right ventricular dysfunction and risk of heart failure and mortality after myocardial infarction
    Leonardo A M Zornoff
    Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    J Am Coll Cardiol 39:1450-5. 2002
    ..The aim of this study was to determine the prognostic value of right ventricular (RV) function in patients after a myocardial infarction (MI)...
  47. doi request reprint (18)F-FDG PET/CT for the assessment of myocardial sarcoidosis
    Hicham Skali
    Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, 70 Francis Street, Shapiro 5th Floor, Room 128, Boston, MA 02115, USA
    Curr Cardiol Rep 15:352. 2013
    ..Accumulating data support the growing role of (18)F-fluorodeoxyglucose ((18)F-FDG) PET in the diagnosis and risk stratification of patients with cardiac sarcoidosis...